Ftse Mib
34.540,45
-0,18%
DAX
18.677,16
-0,26%
S&P 500
5.321,41
0,25%
NASDAQ
16.832,62
0,22%
Bitcoin
69.697,23
-0,62%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Spruce Biosciences Inc (SPRB) Spruce Biosciences Inc (SPRB) Notizie

SPRB

Spruce Biosciences (SPRB)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:SPRB
DataOraFonteTitoloSimboloCompagnia
13/05/202422:09Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SPRBSpruce Biosciences Inc
13/05/202422:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SPRBSpruce Biosciences Inc
13/05/202422:01Business WireSpruce Biosciences Reports First Quarter 2024 Financial Results and Provides Corporate UpdatesNASDAQ:SPRBSpruce Biosciences Inc
01/05/202422:05Business WireSpruce Biosciences to Participate in May Investor ConferencesNASDAQ:SPRBSpruce Biosciences Inc
30/04/202422:05Business WireSpruce Biosciences Announces Additional Poster Presentation at the Pediatric Endocrine Society 2024 Annual MeetingNASDAQ:SPRBSpruce Biosciences Inc
22/04/202422:05Business WireSpruce Biosciences Announces Upcoming Poster Presentation at the Pediatric Endocrine Society 2024 Annual MeetingNASDAQ:SPRBSpruce Biosciences Inc
13/03/202421:08Business WireSpruce Biosciences Reports Full Year 2023 Financial Results and Provides Corporate UpdatesNASDAQ:SPRBSpruce Biosciences Inc
13/03/202421:01Business WireSpruce Biosciences Announces Topline Results from CAHmelia-203 in Adult Classic CAH and CAHptain-205 in Pediatric Classic CAHNASDAQ:SPRBSpruce Biosciences Inc
07/03/202422:07Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:SPRBSpruce Biosciences Inc
06/02/202422:15Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:SPRBSpruce Biosciences Inc
30/01/202422:05Business WireSpruce Biosciences to Present at the Oppenheimer 34th Annual Healthcare Life Sciences ConferenceNASDAQ:SPRBSpruce Biosciences Inc
22/01/202414:00Business WireSpruce Biosciences Completes Enrollment in CAHmelia-204 Study for Adult Classic Congenital Adrenal HyperplasiaNASDAQ:SPRBSpruce Biosciences Inc
05/01/202414:00Business WireSpruce Biosciences Reports Baseline Characteristics from CAHmelia-203 and CAHmelia-204 Studies in Adult Classic CAHNASDAQ:SPRBSpruce Biosciences Inc
04/01/202414:00Business WireSpruce Biosciences Provides Clinical Program Updates and Outlook for 2024NASDAQ:SPRBSpruce Biosciences Inc
03/01/202422:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SPRBSpruce Biosciences Inc
13/11/202322:05Business WireSpruce Biosciences Reports Third Quarter 2023 Financial Results and Provides Corporate UpdatesNASDAQ:SPRBSpruce Biosciences Inc
02/11/202321:05Business WireSpruce Biosciences to Participate in the Jefferies London Healthcare ConferenceNASDAQ:SPRBSpruce Biosciences Inc
18/10/202314:00Business WireSpruce Biosciences Completes Target Enrollment of CAHmelia-203 Study in Adult Classic Congenital Adrenal HyperplasiaNASDAQ:SPRBSpruce Biosciences Inc
28/08/202322:00Business WireSpruce Biosciences to Participate in the H.C. Wainwright 25th Annual Global Investment ConferenceNASDAQ:SPRBSpruce Biosciences Inc
14/08/202322:00Business WireSpruce Biosciences Reports Second Quarter 2023 Financial Results and Provides Corporate UpdatesNASDAQ:SPRBSpruce Biosciences Inc
12/06/202322:00Business WireSpruce Biosciences Announces Acceptance of Abstract for Presentation at the Annual Meeting of the Endocrine Society (ENDO 2023)NASDAQ:SPRBSpruce Biosciences Inc
26/05/202323:41Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SPRBSpruce Biosciences Inc
26/05/202322:14Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SPRBSpruce Biosciences Inc
25/05/202314:00Business WireSpruce Biosciences Appoints Percival Barretto-Ko to Board of DirectorsNASDAQ:SPRBSpruce Biosciences Inc
24/05/202322:05Business WireSpruce Biosciences to Participate in the Jefferies Healthcare ConferenceNASDAQ:SPRBSpruce Biosciences Inc
22/05/202315:30Business WireSpruce Biosciences Honored at CARES Foundation 15th Annual Everyone CARES GalaNASDAQ:SPRBSpruce Biosciences Inc
15/05/202314:00Business WireSpruce Biosciences Reports First Quarter 2023 Financial Results and Provides Corporate UpdatesNASDAQ:SPRBSpruce Biosciences Inc
04/05/202322:05Business WireSpruce Biosciences to Present Findings on Retrospective Analysis of Completion Rates for CAH Studies at Pediatric Endocrine Society 2023 Annual MeetingNASDAQ:SPRBSpruce Biosciences Inc
10/04/202312:02Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:SPRBSpruce Biosciences Inc
05/04/202322:34Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:SPRBSpruce Biosciences Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:SPRB

La tua Cronologia

BIT
STLAM
Stellantis NV
BIT
UCG
Unicredit
BIT
ENI
Eni
BIT
SPM
Saipem
BIT
ISP
Intesa Sanpaolo
BIT
ENEL
Enel
BIT
TIT
Telecom Italia
BIT
BFF
BFF Bank
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
BPE
Bper Banca
BIT
G
Generali
BIT
LDO
Leonardo
BIT
MONC
Moncler
BIT
RACE
Ferrari NV
BIT
STMMI
ST Microelectronics
BIT
TRN
Terna Trasmissione Elett...
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network